Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-06
2007-02-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S201000, C548S496000, C548S504000, C564S027000, C564S047000, C514S419000, C514S595000
Reexamination Certificate
active
11125359
ABSTRACT:
The invention concerns 4-aminomethyl-1-aryl-cyclohexylamine compounds, methods for producing same, pharmaceutical formulations containing said compounds and the use of 4-aminomethyyl-1-aryl-cyclohexylamine compounds for producing medicines and in related methods of treatment.
REFERENCES:
patent: 4483991 (1984-11-01), Freed
patent: 6057338 (2000-05-01), Yang et al.
patent: 6172067 (2001-01-01), Ito et al.
patent: 2005/0277674 (2005-12-01), Hinze et al.
patent: 699 03 953 (2003-03-01), None
patent: WO 98/28326 (1998-07-01), None
patent: WO 01/87838 (2001-11-01), None
patent: WO 02/085357 (2002-10-01), None
patent: WO 02/090317 (2002-11-01), None
patent: WO02090317 (2002-11-01), None
Bregola, et al.“Involvement of the Neuropeptide Orphanin FQ/Nociceptin in Kainate and Kindling Seizures and Epileptogenesis” Epilepsia, 43(Suppl. 5): 18-19 (2002).
Inoue et al., “Pronociceptive Effects of Nociceptin/Orphanin FQ (13-17) at Peripheral and Spinal Level in Mice” J. Pharm. Experimental Therapeutics, 299(1), 213-219 (2001).
Calo et al. “Pharmacology of Nociceptin and its Receptor: A Novel Therapeutic Target” British J. Pharm. 129, 1261-1283 (2000).
Abdulla and Smith, J. Neurosci. 18, 1998, p. 9685-9694.
Ardati et al., Mol. Pharmacol., 51, 1997, p. 816-824.
Calo et al., Br. J. Pharmacol., 129, 2000, 1261-1283.
Jenck et al., Proc. Natl. Acad. Sci. USA 94, 1997, 14854-14858.
King et al., Neurosci. Lett., 223, 1997, 113-116.
Lednicer et al., J. Med. Chem., 23, 1980, 424-430.
Manabe et al., Nature, 394, 1997, p. 577-581.
Meunier et al., Nature 377, 1995, p. 532-535.
Mogil et al., Neuroscience 75, 1996, p. 333-337.
Nishi et al., EMBO J., 16, 1997, p. 1858 1864.
Reinscheid et al., Science 270, 1995, p. 792-794.
Hinze Claudia
Schick Hans
Sundermann Bernd
Crowell & Moring LLP
Grazier Nyeemah A.
Gruenenthal GmbH
McKane Joseph K.
LandOfFree
4-aminomethyl-1-aryl-cyclohexylamine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminomethyl-1-aryl-cyclohexylamine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminomethyl-1-aryl-cyclohexylamine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3843974